For Year 2025-26, Venus Remedies reports the following shareholding: Total Promoters at 41.76%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 2.25%, Domestic Institutional Investors at 1.04%, and Retail at 54.96%. This breakdown provides a quick snapshot of ownership distribution for Venus Remedies in 2025-26.